Physician profile
Augusto A Toraya
NPI 1932269768
$3,943.21
in general payments reported to CMS, 2019-2025
19 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,712 · 2020: $32.47 · 2021: $556 · 2022: $478 · 2023: $385 · 2024: $347 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,164.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $872.67 | 2019-2022 | |
| Allergan, INC. | $642.86 | 2019 | |
| Novo Nordisk INC | $517.43 | 2019-2024 | |
| Medtronic, INC. | $268.08 | 2023-2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $172.11 | 2019 | |
| Amgen INC. | $142.91 | 2025 | |
| Davol INC. | $136.49 | 2021 | |
| Impel Pharmaceuticals INC. | $135.84 | 2023 | Trudhesa |
| Madrigal Pharmaceuticals | $125.51 | 2025 | Rezdiffra |
| Pacira Pharmaceuticals Incorporated | $121.37 | 2019 | |
| Acadia Pharmaceuticals INC | $117.05 | 2024 | Daybue |
| Shire North American Group INC | $115.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $110.53 | 2019 | |
| Sanofi-Aventis U.S. LLC | $107.55 | 2021 | |
| Phathom Pharmaceuticals, INC. | $107.17 | 2024 | Voquezna |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rare Disease Therapeutics, INC. | $96.84 | 2019 | |
| Lilly USA, LLC | $86.58 | 2019 | |
| Penumbra, INC. | $33.76 | 2025 | Indigo System |
| Abiomed | $32.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Augusto Toraya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.